Timiperone
Timiperone, sold under the brand name Tolopelon, is an antipsychotic of the butyrophenone class which is marketed in Japan.[1][2][3] It is similar in chemical structure to benperidol but has a thiourea group instead of a urea group.
![]() | |
| Clinical data | |
|---|---|
| Trade names | Tolopelon |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.055.328 |
| Chemical and physical data | |
| Formula | C22H24FN3OS |
| Molar mass | 397.50 g/mol g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| | |
References
- Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 1030–. ISBN 978-3-88763-075-1.
- Yamasaki, T; Kojima, H; Tanaka, M; et al. (1981). "Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties". Arzneimittelforschung. 31: 707–15. PMID 6113834.
- "Effect of Timiperone, a New Antipsychotic Drug, on the Sleep-Wakefulness Cycle in Cats". The Japanese Journal of Pharmacology. 39 (3): 391–394. 1985.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.
